141 related articles for article (PubMed ID: 6113451)
1. Control of epidemic meningococcal meningitis by mass vaccination.
Mohammed I; Zaruba K
Lancet; 1981 Jul; 2(8237):80-2. PubMed ID: 6113451
[No Abstract] [Full Text] [Related]
2. Control of epidemic meningococcal meningitis by mass vaccination. I. Further epidemiological evaluation of groups A and C vaccines in northern Nigeria.
Mohammed I; Obineche EN; Onyemelukwe GC; Zaruba K
J Infect; 1984 Sep; 9(2):190-6. PubMed ID: 6438244
[TBL] [Abstract][Full Text] [Related]
3. Control of meningococcal infection in the African meningitis belt by selective vaccination.
Greenwood BM; Wali SS
Lancet; 1980 Apr; 1(8171):729-32. PubMed ID: 6103155
[TBL] [Abstract][Full Text] [Related]
4. Trial of a serogroup A meningococcus polysaccharide vaccine in Nigeria.
Sanborn WR; Bencić Z; Cvjetanović B; Gotschlich EC; Pollock TM; Sippel JE
Prog Immunobiol Stand; 1971; 5():497-505. PubMed ID: 4633977
[No Abstract] [Full Text] [Related]
5. Control of epidemic meningococcal meningitis by mass vaccination. II. Persistence of antibody four years after vaccination.
Mohammed I; Onyemelukwe GC; Obineche EN; Gupta N; Oyeyinka GO
J Infect; 1984 Sep; 9(2):197-202. PubMed ID: 6438245
[TBL] [Abstract][Full Text] [Related]
6. [Preventive effectiveness of an urgent mass vaccination with purified meningococcal polysaccharide vaccine observed during a meningitis epidemic].
Wu C
Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Dec; 6(6):344-6. PubMed ID: 3938683
[No Abstract] [Full Text] [Related]
7. Outbreak of group C meningococcal disease in Australian Aboriginal children.
Booy R
Lancet; 1995 Aug; 346(8974):572-3. PubMed ID: 7658793
[No Abstract] [Full Text] [Related]
8. [African aspects of vaccination in prevention of purulent meningitis].
Rey M
Ann Soc Belg Med Trop; 1980 Sep; 60(3):237-52. PubMed ID: 6788000
[No Abstract] [Full Text] [Related]
9. Epidemic meningococcal meningitis in central Australia, 1987-1991.
Patel MS; Merianos A; Hanna JN; Vartto K; Tait P; Morey F; Jayathissa S
Med J Aust; 1993 Mar; 158(5):336-40. PubMed ID: 7605395
[TBL] [Abstract][Full Text] [Related]
10. Effect of group-A meningococcal vaccine in army recruits in Finland.
Mäkelä PH; Käyhty H; Weckström P; Sivonen A; Renkonen OV
Lancet; 1975 Nov; 2(7941):883-6. PubMed ID: 53370
[TBL] [Abstract][Full Text] [Related]
11. Who should be given meningococcal vaccine?
Lancet; 1978 Dec; 2(8101):1185-6. PubMed ID: 82146
[No Abstract] [Full Text] [Related]
12. [Suppurative bacterial meningitis and the outlook for specific prevention].
Demina AA; Deviatkina NP
Zh Mikrobiol Epidemiol Immunobiol; 1984 May; (5):3-10. PubMed ID: 6429984
[No Abstract] [Full Text] [Related]
13. [Survey on efficacy of inoculating purified polysaccharide vaccines as an emergency measure in preventing epidemic meningitis].
Xu CH
Zhonghua Liu Xing Bing Xue Za Zhi; 1982 Dec; 3(6):328-30. PubMed ID: 6821030
[No Abstract] [Full Text] [Related]
14. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway.
Bjune G; Høiby EA; Grønnesby JK; Arnesen O; Fredriksen JH; Halstensen A; Holten E; Lindbak AK; Nøkleby H; Rosenqvist E
Lancet; 1991 Nov; 338(8775):1093-6. PubMed ID: 1682541
[TBL] [Abstract][Full Text] [Related]
15. Meningococcal immunisation and protection from epidemics.
Hassan J; Massougbodji A; Chippaux JP; Massit B; Josse R
Lancet; 1998 Aug; 352(9125):407-8. PubMed ID: 9717959
[No Abstract] [Full Text] [Related]
16. A serogroup A meningococcal polysaccharide vaccine: studies in the Sudan to combat cerebrospinal meningitis caused by Neisseria meningitidis group A.
Erwa HH; Haseeb MA; Idris AA; Lapeyssonnie L; Sanborn WR; Sippel JE
Bull World Health Organ; 1973; 49(3):301-5. PubMed ID: 4211056
[TBL] [Abstract][Full Text] [Related]
17. Meningococcal immunisation in Ghana.
de Chabalier F; Chippaux JP; Massougbodji A
Lancet; 2000 Jun; 355(9222):2252; author reply 2252-3. PubMed ID: 10881917
[No Abstract] [Full Text] [Related]
18. Control of group C meningococcal disease in Australian aboriginal children by mass rifampicin chemoprophylaxis and vaccination.
Pearce MC; Sheridan JW; Jones DM; Lawrence GW; Murphy DM; Masutti B; McCosker C; Douglas V; George D; O'Keefe A
Lancet; 1995 Jul; 346(8966):20-3. PubMed ID: 7603139
[TBL] [Abstract][Full Text] [Related]
19. Response of children to Neisseria meningitidis polysaccharide vaccines.
Monto AS; Brandt BL; Artenstein MS
J Infect Dis; 1973 Apr; 127(4):394-400. PubMed ID: 4632878
[No Abstract] [Full Text] [Related]
20. Polysaccharide meningococcal vaccines--current status.
Gold R
Hosp Pract; 1979 Dec; 14(12):41-8. PubMed ID: 116953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]